A method of determining the immune response of a mammal to circulating tumour marker proteins is described in which a sample of bodily fluid, for example plasma or serum, is contacted with a panel of two or more distinct tumour marker antigen. The presence of complexes between the tumour marker antigens...http://www.google.es/patents/US8114604?utm_source=gb-gplus-sharePatente US8114604 - Tumour markers
